MetaCap

Windward Bio Group SEC Filings

NASDAQ: WWBHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

24.29+0.275 (+1.15%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Windward Bio Group filing overview

This page lists 17 recent SEC filings by Windward Bio Group (WWB), including 12 4, 2 F-1/A, 1 424B4, 1 6-K. Form 10-K is the audited annual report, 10-Q the quarterly report, 8-K covers material events, and Form 4 reports insider transactions. All documents link directly to SEC EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

WWB SEC filings

Windward Bio Group SEC filings
FiledFormDescriptionDocument
Nov 18, 20264Statement of changes in beneficial ownershipView on EDGAR
Nov 18, 20264Statement of changes in beneficial ownershipView on EDGAR
Nov 18, 20264Statement of changes in beneficial ownershipView on EDGAR
Nov 16, 2026424B4ProspectusView on EDGAR
Nov 16, 20266-KReport of foreign private issuerView on EDGAR
Nov 16, 20264Statement of changes in beneficial ownershipView on EDGAR
Nov 16, 20264Statement of changes in beneficial ownershipView on EDGAR
Nov 16, 20264Statement of changes in beneficial ownershipView on EDGAR
Nov 16, 20264Statement of changes in beneficial ownershipView on EDGAR
Nov 16, 20264Statement of changes in beneficial ownershipView on EDGAR
Nov 16, 20264Statement of changes in beneficial ownershipView on EDGAR
Nov 16, 20264Statement of changes in beneficial ownershipView on EDGAR
Nov 16, 20264Statement of changes in beneficial ownershipView on EDGAR
Nov 16, 20264Statement of changes in beneficial ownershipView on EDGAR
Nov 9, 2026F-1/ARegistration statement (foreign issuer) (amendment)View on EDGAR
Oct 30, 2026F-1/ARegistration statement (foreign issuer) (amendment)View on EDGAR
Oct 23, 2026F-1Registration statement (foreign issuer)View on EDGAR

Related